Bloomberg says the boom in GLP-1 use has opened a risky trade in weight loss drugs brought into Brazil illegally.
Recap by typeshit. Full story at Bloomberg.com.
STAT
Members of Congress from both parties want the FDA to stop imports of copycat versions of Eli Lilly's experimental obesity drug, which is still in trials.
The pharmacy boards group, per InsideHealthPolicy, ties reported deaths linked to retatrutide to weak enforcement against gray-market peptide sellers.
Judge Raphael Leite Guedes in Maranhão found tirzepatide counts as a home-use drug under Law 9,656/98, even when a clinic gives the shots.
Inc. reports that some Georgia clinics are still marketing an unapproved Lilly weight loss drug even as the company moves against its sale.
A short BusinessWorld Online piece on what the newest weight loss pill is called. Little detail is available beyond the title.
Ingredient makers tell Nutrition Insight that companion products need trial evidence and careful claims, with HTBA pointing to fatigue on treatment.
Loading…